Jayhawk Capital Management’s Global Cord Blood Corporation CO Stock Holding History

Jayhawk Capital Management’s Portfolio CO Stock Details CO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-120,000	Closed	-$49K	–	2
2018 Q2	$49K	Sell	120,000 -328,500	-73%	-$3.15M	0.03%	2
2018 Q1	$183K	Sell	448,500 -80,000	-15%	-$817K	0.12%	2
2017 Q4	$444K	Buy	+528,500	New	+$5.78M	0.29%	3

Other funds holding CO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Jayhawk Capital Management's CO Position: Q4 2019 in Review

Jayhawk Capital Management reduced its Global Cord Blood Corporation (CO) stake by 6.1% in Q4 2019, selling an estimated $3.71M and leaving 11,973,786 shares worth $59.9M. The position accounts for 100% of the portfolio, ranked #1.

Jayhawk Capital Management first reported a position in CO in Q4 2017 and has held it in 9 quarters since. The position peaked at $153M in Q4 2017. 35 funds tracked by Wall St. Rank hold CO as of Q4 2019.

Jayhawk Capital Management held 11,973,786 shares of Global Cord Blood Corporation worth $59.9M as of Q4 2019.
Jayhawk Capital Management sold 776,214 Global Cord Blood Corporation shares in Q4 2019, an estimated $3.71M.
Global Cord Blood Corporation made up 100% of Jayhawk Capital Management's portfolio in Q4 2019, its #1 holding.
Jayhawk Capital Management first reported a position in Global Cord Blood Corporation in Q4 2017 and has held it in 9 quarters since.
Jayhawk Capital Management's Global Cord Blood Corporation position peaked at $153M in Q4 2017.
35 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2019.

Based on Jayhawk Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.